Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07164924Completed

Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility

Role: collaborator

NCT05648292Unknown

The Relationships Between Personal Identity, Autobiographical Memory and Future Thinking in People With Multiple Sclerosis

Role: collaborator

NCT01207856Not ApplicableCompleted

Randomised Controlled Clinical Trial of Cognitive Rehabilitation in Multiple Sclerosis

Role: collaborator

All 3 trials loaded